Immunologie intégrative des tumeurs et immunothérapie des cancers
TutelageInserm, Institut Gustave Roussy, EPHE, Université Paris-Saclay
Key wordshypoxia, tumor microenvironment, immunotherapy, hif, ctl
The laboratory Tumor Integrative Immunology is studying tumor antigens, T-cell reactivity, the impact of the tumor microenvironment on tumor resistance (role on plasticity in particular) and more generally genetics and biology of breast cancer, lung, kidneys and cancers related to melanomas. This work are undertaken thanks to partnerships with industrial companies, which has allowed 2 patents filing as well as the creation of 2 startups and the development of new innovative immunotherapy approaches.
The 20 latest publications
Number of publications of the laboratory by scientific field (2016-2021)
Every paper can be classified in one or more scientific fields. The figure below shows the lab's number of publications in each scientific field, according to the ASJC classification (Elsevier)